Stocktoria
Tarsus Pharmaceuticals, Inc. TARS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-16
Tarsus Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1,457,124 | $91.7M | 3.42% |
| BlackRock Finance, Inc. | 3,266,714 | $88.8M | 7.68% |
| D. E. Shaw & Co., Inc. | 710,559 | $44.7M | 1.67% |
| CITADEL ADVISORS LLC | 274,137 | $17.3M | 0.64% |
| AQR CAPITAL MANAGEMENT LLC | 42,003 | $2.6M | 0.1% |
| TWO SIGMA INVESTMENTS, LP | 36,038 | $2.3M | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 9,300 | $585,342 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.